Company Info
Phone(617) 607-0800
Year Established
1998
Ticker
ENTA
Exchange
NASDAQ
Contacts
Jay R. Luly, Ph.D.President & CEO
Yat Sun Or, Ph.D.
Senior VP, R&D & CSO
Paul J. Mellett
CFO
Scott T. Rottinghaus, M.D.
CMO
Nathaniel S. Gardiner, J.D.
General Counsel
Tara L. Kieffer, Ph.D.
Senior VP, New Product Strategy and Development
Brendan Luu
Senior VP, Business Development
Company Description
Enantaﾒs chemistry-driven approach and drug discovery capabilities are focused on small molecule drugs for the treatment of viral infections and liver diseases.